.png)
Description:
Wegovy is indicated for weight management in patients, in conjunction with a reduced-calorie diet and increased physical activity.
About the Service:
Objectives of treatment
This treatment is used to reduce the Body Mass Index (BMI) in obese patients (BMI 30+) or in overweight patients (BMI of 27-30) with one or more weight-related co-morbidities.
Who is this treatment available to?
Patients aged between 18 and 74 years.
Patients with an initial BMI of 30 or greater.
Patients in which a supervised diet, behaviour modification and increasing physical activity failed to achieve a realistic reduction in weight.
Patients with an initial BMI of 27 or greater in the presence of at least one weight-related comorbidity such as:
̵ Hypertension (High blood pressure)
̵ Dyslipidaemia (abnormal amount of lipids - 'bad' cholesterol in your blood.
̵ Obstructive sleep apnoea
̵ Type 2 diabetes mellitus)
This treatment is only available for ages between 18 and 74 years.
Furthermore, Any Cancellation within 48 hours prior to appointment will incur a charge of 20% of total service cost.